The number of Chapter 11 bankruptcies among larger US medical companies — including physician groups — fell to 57 in 2024 from 2023’s 79 filings, a […]
Switching from an originator biologic to a biosimilar can sometimes trigger a nocebo effect, where negative expectations lead to worsened symptoms, reduced treatment efficacy, or perceived […]
Highly Pathogenic Avian Influenza is the suspected cause of death in wild and domestic birds across Massachusetts, according to a press release from Massachusetts Department of […]
AstraZeneca has launched new lawsuits against four generic drug manufacturers in an ongoing patent battle over its cancer drug Lynparza (olaparib), approved to treat ovarian, pancreatic, […]
A holistic or integrative approach to hair loss considers the hair growth cycle and hair loss from a nutritional, psychosocial, and physiological perspective, according to dermatologists […]
(Reuters) – The U.S. Centers for Disease Control and Prevention is seeking to withdraw all papers involving its researchers that are being considered for publication by […]
WASHINGTON (Reuters) – The U.S. State Department said on Saturday that the President’s Emergency Plan for AIDS Relief (PEPFAR) — the world’s leading HIV initiative – […]
(Reuters) – The U.S. Centers for Disease Control and Prevention and other federal health agencies on Friday took down webpages with information on HIV statistics and […]
LONDON (Reuters) -AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England, citing a cut in […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.